Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal imbalances can cause acne, excess hair growth, and hair loss in women, needing combined medical and emotional care.

Hormonal imbalances in women can cause acne, excess hair growth, and hair loss, needing combined medical and mental health care.

Hormonal imbalances in women can cause acne, excess hair growth, and hair loss, needing combined medical and mental health care.

Hormonal changes and conditions like polycystic ovarian syndrome are major causes of adult acne in women, with varying prevalence among different ethnicities.

Chemotherapy provides symptom relief and extends life in 30-50% of gynecological cancer cases, but has only cured choriocarcinoma.

Cyproterone acetate is effective for treating hirsutism and acne in women by blocking androgens in the skin and also works as a contraceptive.

Young female athletes should be informed about health risks like menstrual issues and bone problems from excessive sports.

COVID-19 affects patients on chemotherapy for gynecological cancer negatively.

Using 5α-reductase inhibitors for hair loss in women doesn't increase cancer risk.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

Platelet-rich plasma shows promise for treating various female reproductive health issues but requires more research.

Scalp cooling reduces hair loss and improves quality of life during chemotherapy.

Women with PCOS have distinct clinical and hormonal differences, requiring thorough evaluation for proper diagnosis and management.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Women with PCOS often have different clinical signs, hormone levels, and gynecological issues compared to those without the condition.

19.7% of Afro-Caribbean women in Tobago have PCOS.

Chemotherapy reduces taste and smell, but they mostly recover after treatment; adding spices may help improve appetite.

PRP is popular for hair restoration but needs better research methods to confirm its effectiveness and safety.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Less than 10% of nursing students have PCOS, but many show symptoms and poor health habits, needing more education and yearly check-ups.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

New skin lesions on the scrotum or vulva in patients with a history of internal cancer could indicate rare skin metastasis.

Chemotherapy is crucial for treating gynecological cancers but requires careful management due to severe side effects.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

In 2009, there were new medical devices, treatments for gynecological conditions, updated health guidelines, and legal developments in women's health.

The issue covers reproductive health topics like cancer markers, incontinence treatments, and the impact of pre-term birth.

Most patients experienced significant but reversible hair loss during treatment.

Environmental and social factors greatly affect women's reproductive health.